Regina M Black

age ~55

from East Orange, NJ

Get Report

Also known as:

Connected to:

Regina Black Phones & Addresses

License #:

P008974 - Expired

Category:

Social Work

Issued Date:

Jun 12, 2014

Expiration Date:

Jul 31, 2016 - Expidre

Type:

Clinical Social Worker Associate

License #:

13801 - Active

Category:

Pharmacy

Issued Date:

Dec 8, 2011

Effective Date:

Dec 8, 2011

Expiration Date:

Jan 1, 2018

Type:

Pharmacist

N-Substituted Indoles Useful In The Treatment Of Diabetes
view source
US Patent:

6525083, Feb 25, 2003
Filed:

Jul 25, 2001
Appl. No.:

09/912961
Inventors:

Regina Marie Black - Cranford NJ
Anthony Brian Jones - Clavering, GB
Harold Blair Wood - Cranford NJ
Assignee:

Merck Co., Inc. - Rahway NJ
International Classification:

A61K 31405
US Classification:

514415, 548510, 548511
Abstract:

Certain N-substituted indoles having aryloxyacetic acid, substituents are agonists or partial agonists of PPAR gamma, and are useful in the treatment, control or prevention of non-insulin dependent diabetes mellitus (NIDDM), hyperglycemia, dyslipidemia, hyperlipidemia, hypercholesterolemia, hypertriglyceridemia, atherosclerosis, obesity, vascular restenosis, inflammation, and other PPAR mediated diseases, disorders and conditions.

Indoles Having Anti-Diabetic Activity
view source
US Patent:

7186746, Mar 6, 2007
Filed:

Aug 27, 2003
Appl. No.:

10/524697
Inventors:

Sheryl D. Debenham - Scotch Plains NJ, US
Kun Liu - Edison NJ, US
Peter T. Meinke - Plainfield NJ, US
Harold B. Wood - Westfield NJ, US
Regina M. Black - Cranford NJ, US
Assignee:

Merck & Co., Inc. - Rahway NJ
International Classification:

A61K 31/40
C07D 209/36
US Classification:

514419, 548484
Abstract:

Indoles having aryloxyalkanoic acid substituents or arylalkanoic acid substituents are agonists or partial agonists of PPAR gamma and are useful in the treatment and control of hyperglycemia that is symptomatic of type II diabetes, as well as dyslipidemia, hyperlipidemia, hypercholesterolemia, hypertriglyceridemia, and obesity that are often associated with type 2 diabetes.

Indoles Having Anti-Diabetic Activity
view source
US Patent:

7345085, Mar 18, 2008
Filed:

Mar 6, 2007
Appl. No.:

11/714341
Inventors:

Sheryl D. Debenham - Scotch Plains NJ, US
Kun Liu - Edison NJ, US
Peter T. Meinke - Plainfield NJ, US
Harold B. Wood - Westfield NJ, US
Regina M. Black - Cranford NJ, US
Assignee:

Merck & Co., Inc. - Rahway NJ
International Classification:

A61K 31/40
C07D 209/36
US Classification:

514419, 548484
Abstract:

Indoles having aryloxyalkanoic acid substituents or arylalkanoic acid substituents are agonists or partial agonists of PPAR gamma and are useful in the treatment and control of hyperglycemia that is symptomatic of type II diabetes, as well as dyslipidemia, hyperlipidemia, hypercholesterolemia, hypertriglyceridemia, and obesity that are often associated with type 2 diabetes.

Indoles Having Anti-Diabetic Activity
view source
US Patent:

7393960, Jul 1, 2008
Filed:

Aug 28, 2003
Appl. No.:

10/525470
Inventors:

Peter T. Meinke - Plainfield NJ, US
Harold B. Wood - Westfield NJ, US
Regina M. Black - Cranford NJ, US
Assignee:

Merck & Co., Inc. - Rahway NJ
International Classification:

C07D 261/20
A01N 43/80
US Classification:

548241, 514379
Abstract:

Indoles having aryloxyalkanoic acid substituents or arylalkanoic acid substituents are agonists or partial agonists of PPAR gamma and are useful in the treatment and control of hyperglycemia that is symptomatic of type II diabetes, as well as dyslipidemia, hyperlipidemia, hypercholesterolemia, hypertriglyceridemia, and obesity that are often associated with type 2 diabetes.

Aza Cyclohexapeptide Compounds
view source
US Patent:

53788044, Jan 3, 1995
Filed:

Mar 16, 1993
Appl. No.:

8/032847
Inventors:

James M. Balkovec - North Plainfield NJ
Regina M. Black - Cranford NJ
Frances A. Bouffard - Scotch Plains NJ
Assignee:

Merck & Co., Inc. - Rahway NJ
International Classification:

C07K 764
US Classification:

530317
Abstract:

Aza cyclohexapeptide compounds are disclosed with a nitrogen attached to the cyclohexapeptide ring at the 5-carbon of the 4-hydroxyornithine component. Such compounds are represented by the formula: ##STR1## The compounds are disclosed as having antifungal, antiprotozoal and anti-Pneumocystis carinii activity.

Aza Cyclohexapeptide Compounds
view source
US Patent:

57927464, Aug 11, 1998
Filed:

Oct 28, 1996
Appl. No.:

8/741645
Inventors:

James M. Balkovec - North Plainfield NJ
Frances Aileen Bouffard - Scotch Plains NJ
Regina M. Black - Cranford NJ
Assignee:

Merck & Co., Inc. - Rahway NJ
International Classification:

A61K 3812
C07K 752
US Classification:

514 11
Abstract:

Ceretain aza cyclohexapeptide compounds have been found to have superior antibiotic properties. Novel processes for their preparation are also described.

Process For Reduction Of Certain Cyclohexapeptide Compounds
view source
US Patent:

51590590, Oct 27, 1992
Filed:

May 29, 1990
Appl. No.:

7/529295
Inventors:

James M. Balkovec - North Plainfield NJ
Regina C. Black - Cranford NJ
Assignee:

Merck & Co., Inc. - Rahway NJ
International Classification:

A61K 3702
C12P 2104
US Classification:

530317
Abstract:

Process for producing a compound of the formula ##STR1## by selectively reducing a compound of the formula ##STR2## in a strong acid medium with excess molar equivalent of reducing agent so that the OH adjacent to X. sub. 1 is reduced to H and if Q is OH in the starting material, it optionally may be reduced H.

Aza Cyclohexapeptide Compounds
view source
US Patent:

55146503, May 7, 1996
Filed:

Aug 29, 1994
Appl. No.:

8/298479
Inventors:

James M. Balkovec - North Plainfield NJ
Regina M. Black - Cranford NJ
Frances A. Bouffard - Scotch Plains NJ
Assignee:

Merck & Co., Inc. - Rahway NJ
International Classification:

A61K 3812
US Classification:

514 11
Abstract:

Ceretain aza cyclohexapeptide compounds have been found to have superior antibiotic properties. Novel processes for their preparation are also described.